Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma-a case report

被引：1
|
作者：
Leven, Anna-Sophia [1 ]
Becker, Juergen C. [2 ,3 ]
Poettgen, Christoph [4 ]
Schadendorf, Dirk [1 ,5 ,6 ,7 ]
Ugurel, Selma [1 ,5 ,6 ,7 ]
Tasdogan, Alpaslan [1 ,5 ,6 ,7 ]
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany
[2] Univ Med, Translat Skin Canc Res, Essen, Germany
[3] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Heidelberg, Germany
[4] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Radiotherapy, Essen, Germany
[5] German Canc Consortium, Partner Site Essen, Essen, Germany
[6] Univ Duisburg Essen, Natl Ctr Tumor Dis NCT West, Campus Essen, Essen, Germany
[7] Univ Duisburg Essen, Res Ctr One Hlth, Res Alliance Ruhr, Essen, Germany
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年 / 63卷 / 02期
关键词：
OPEN-LABEL;
D O I：
10.1111/ijd.16986
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e69 / e71
页数：3
相关论文
共 50 条
  • [1] A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard L.
    Silk, Ann W.
    Thakuria, Manisha
    Miller, David M.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (07) : 299 - 302
  • [2] A retrospective study of ipilimumab plus nivolumab in anti-PD-L1/PD-1-refractory merkel cell carcinoma.
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard E.
    Miller, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Successful Radiation Therapy with Avelumab-Reinduction in Patients with PD-1/PD-L1-refractory Merkel Cell Carcinoma
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 27 - 27
  • [4] Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1/PD-1-refractory Merkel Cell Carcinoma
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard L.
    Miller, David M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (10) : 2840 - 2840
  • [5] Salvage nivolumab plus ipilimumab after prior PD-1/PD-L1 inhibitor treatment in metastatic renal cell carcinoma: A meta-analysis.
    Yin Ming
    Mori-Vogt, Sherry
    Hinkley, Megan
    Parikh, Anish B.
    Yang Yuanquan
    Collier, Katharine
    Miah, Abdul
    Li Mingjia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [6] Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
    VanderWalde, Ari
    Bellasea, Shay L.
    Kendra, Kari L.
    Khushalani, Nikhil I.
    Campbell, Katie M.
    Scumpia, Philip O.
    Kuklinski, Lawrence F.
    Collichio, Frances
    Sosman, Jeffrey A.
    Ikeguchi, Alexandra
    Victor, Adrienne I.
    Truong, Thach-Giao
    Chmielowski, Bartosz
    Portnoy, David C.
    Chen, Yuanbin
    Margolin, Kim
    Bane, Charles
    Dasanu, Constantin A.
    Johnson, Douglas B.
    Eroglu, Zeynep
    Chandra, Sunandana
    Medina, Egmidio
    Gonzalez, Cynthia R.
    Baselga-Carretero, Ignacio
    Vega-Crespo, Agustin
    Garcilazo, Ivan Perez
    Sharon, Elad
    Hu-Lieskovan, Siwen
    Patel, Sapna P.
    Grossmann, Kenneth F.
    Moon, James
    Wu, Michael C.
    Ribas, Antoni
    NATURE MEDICINE, 2023, 29 (09) : 2278 - +
  • [7] Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
    Ari VanderWalde
    Shay L. Bellasea
    Kari L. Kendra
    Nikhil I. Khushalani
    Katie M. Campbell
    Philip O. Scumpia
    Lawrence F. Kuklinski
    Frances Collichio
    Jeffrey A. Sosman
    Alexandra Ikeguchi
    Adrienne I. Victor
    Thach-Giao Truong
    Bartosz Chmielowski
    David C. Portnoy
    Yuanbin Chen
    Kim Margolin
    Charles Bane
    Constantin A. Dasanu
    Douglas B. Johnson
    Zeynep Eroglu
    Sunandana Chandra
    Egmidio Medina
    Cynthia R. Gonzalez
    Ignacio Baselga-Carretero
    Agustin Vega-Crespo
    Ivan Perez Garcilazo
    Elad Sharon
    Siwen Hu-Lieskovan
    Sapna P. Patel
    Kenneth F. Grossmann
    James Moon
    Michael C. Wu
    Antoni Ribas
    Nature Medicine, 2023, 29 : 2278 - 2285
  • [8] PD-1 Blockade as a therapeutic Option for metastatic Merkel Cell Carcinoma
    Winkler, J. K.
    Bender, C.
    Enk, A.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 12 - 13
  • [9] PD-1 Blockade in an HIV Patient with Metastatic Merkel Cell Carcinoma
    Gellrich, F.
    Garzarolli, M.
    Blum, S.
    Beissert, S.
    Spornraft-Ragaller, P.
    Boashie, U.
    Meier, F.
    Rauschenberg, R.
    AKTUELLE DERMATOLOGIE, 2018, 44 (06) : 268 - 272
  • [10] Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    Ferdinandus, Justin
    Fendler, Wolfgang P.
    Lueckerath, Katharina
    Berliner, Christoph
    Kurzidem, Sabine
    Hadaschik, Eva
    Klode, Joachim
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Herrmann, Ken
    Becker, Juergen C.
    Ugurel, Selma
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 396 - 398
12345